Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells

Molecular Carcinogenesis

Volumn 50, Issue 8, 2011, Pages 635-642

  Okabe, Kyoko ^a   Hayashi, Mai ^a   Yamawaki, Yasuna ^a   Teranishi, Miki ^a   Honoki, Kanya ^b   Mori, Toshio ^b   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; Gene expression; LPA; Lpa5; Rat

Indexed keywords

LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 5; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL GROWTH; CELL LINE RH7777; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; GLIOMA CELL; HEPATOMA CELL; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG ADENOCARCINOMA; LUNG TUMOR; NEUROBLASTOMA CELL; NONHUMAN; OSTEOSARCOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ADENOCARCINOMA; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MUTATION; NEOPLASMS; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID;

RATTUS;

EID: 79960002662     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20750     Document Type: Article

References (33)

1. Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem 2004; 73: 321-354.
2. Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res 1999; 5: 4308-4318.
3. Goetzl EJ, Dolezalova H, Kong Y, Hu YL, Jaffe RB, Kalli KR, Conover CA. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 1999; 59: 5370-5375.
4. Contos JJA, Fukushima N, Weiner JA, Kaushal D, Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000; 97: 13383-13389.
5. Contos JJA, Ishii I, Fukushima N, Kingsbury MA, Ye X, Kawamura S, Brown JH, Chun J. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 2002; 22: 6921-6929.
6. Fang X, Schummer M, Mao M, Yu S, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J, Mills GB. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 2002; 1582: 257-264.
7. Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, Nakano H. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 2003; 192: 161-169.
8. An S, Bleu T, Halmark OG, Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 1998; 273: 7906-7910.
9. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 1999; 274: 27776-27785.
10. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003; 278: 25600-25606.
11. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. GPR92 as a new G12/13 and Gq coupled lysophosphatidic acid receptor that increases cAMP: LPA5. J Biol Chem 2006; 281: 23589-23597.
12. Pasternack SM, von Kügelgen I, Aboud KAJ, Lee Y-A, Rüschendorf F, Voss K, AHillmer AM, Molderings GJ, Franz T, Ramirez A, Nürnberg P, Nöthen MM, Berz RC. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 2008; 40: 329-334.
13. Shimomura Y, Wajid M, Ishii Y, Shapiro L, Petukhowa L, Gordon D, Christiano AM. Disruption of P2Y5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair. Nat Genet 2008; 40: 335-339.
14. Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, Kishi Y, Yamaguchi H, Sasaki S, Sako A, Konishi T, Arai H, Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investig 2004; 84: 1352-1362.
15. Tsujiuchi T, Shimizu K, Onishi M, Shigemura M, Shano S, Honoki K, Fukushima N. Aberrant expressions of lysophosphatidic acid receptor genes in lung and liver tumors of rats. J Toxicol Pathol 2006; 19: 137-141.
16. Yamada T, Furukawa M, Hotta M, Yamasaki A, Honoki K, Fukushima N, Tsujiuchi T. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem Biophys Res Commun 2009; 378: 424-427.
17. Obo Y, Yamada T, Furukawa M, Hotta M, Honoki K, Fukushima N, Tsujiuchi T. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res 2009; 660: 47-50.
18. Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, Honoki K, Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun 2006; 349: 1151-1155.
19. Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A Lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 2008; 1783: 748-759.
20. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001; 61: 3750-3759.
21. Shida D, Kitayama J, Yanaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003; 63: 1706-1711.
22. Yu S, Murph MM, Lu Y, liu S, Hall HS, Liu J, Stephens C, Fang X, Mills GB. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 2008; 100: 1630-1642.
23. Ohashi K, Tsutsumi M, Tsujiuchi T, Kobitsu K, Okajima E, Nakajima Y, Nakano H, Takahama M, Mori Y, Konishi Y. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicines-induced cell cycle disturbance in partially hepatecomized rats. Cancer Res 1996; 56: 3473-3479.
24. Konishi Y, Denda A, Kondo H, Takahashi S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. Jpn J Cancer Res 1976; 67: 773-780.
25. Hooks SB, Santos WL, Im D-S, Heise CE, Macdonald TL, Lynch KR. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. J Biol Chem 2001; 276: 4611-4621.
26. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: Subtypes and biological actions. Annu Rev Pharmacol Toxicol 2010; 50: 157-186.
27. Jones PA. DNA methylation and cancer. Oncogene 2002; 21: 5358-5360.
28. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
29. Yanagida K, Ishii S, Hamano F, Noguchi K, Shimizu T. LPA4/p2y9/GPR23 mediates Rho-dependent morphological changes in a rat neural cell line. J Biol Chem 2007; 282: 5814-5824.
30. Iguchi T, Sakata K, Yoshizaki K, Tago K, Mizuno N, Itoh H. Orphan G protein-coupled receptor GRP56 regulates neural progenitor cell migration via a Gα12/13 and Rho pathway. J Biol Chem 2008; 283: 14469-14478.
31. Smith NJ, Stoddart LA, Devine NM, Jenkins L, Milligan G. The action and mode of binding of thiazolidine ligands at free fatty acid receptor 1. J Biol Chem 2009; 284: 17527-17539.
32. Nishimura A, Kitano K, Takasaki J, Taniguchi M, Mizuno N, Tago K, Hakoshima T, Itoh H. Structure basis for the specific inhibition of heterotrimetric Gq protein by a small molecule. Proc Natl Axad Sci USA 2010; 107: 13666-13671.
33. Wakabayashi N, Tsujino M, Tajiri M, Taki M, Koshino A, Ikeda H, Fukushima N, Tsujiuchi T. No mutations of lysophosphatidic acid receptor genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. J Toxicol Pathol 2010; 3: 63-66.